Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease

BACKGROUND: Deep brain stimulation (DBS) is a well-established treatment option for select patients with Parkinson’s Disease (PD). However, response to DBS varies, therefore, the ability to predict who will have better outcomes can aid patient selection. Some PD-related monogenic mutations have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Esther, Ahmed, Sarah, Li, Ryan, Bandres-Ciga, Sara, Blauwendraat, Cornelis, Dustin, Irene, Scholz, Sonja, Hallett, Mark, Ehrlich, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071605/
https://www.ncbi.nlm.nih.gov/pubmed/37016359
http://dx.doi.org/10.1186/s12883-023-03188-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071605/
https://www.ncbi.nlm.nih.gov/pubmed/37016359
http://dx.doi.org/10.1186/s12883-023-03188-5

Ejemplares similares